🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04832568
Recruiting Observational

Perioperative EEG-Monitoring and Postoperative Delirium in Patients Undergoing Cardiovascular Surgery

NCT04832568 · tracked via the Priya Life Science China tracker
Sponsor
Huazhong University of Science and Technology
Phase
Observational
Started
2021-06-17
Last updated
2026-03-31

Condition(s) studied

Delirium

Study summary

Postoperative delirium is common in patients undergoing cardiovascular surgery and associated with poor outcomes. However the pathogenesis of postoperative delirium is poorly understood. Multichannel electroencephalogram is a recognized tool for identifying neurophysiologic states during anesthesia, sleep, and arousal. The aim of the current study is to evaluate the mechanisms and predictors of postoperative delirium in patients undergoing cardiovascular surgery using electroencephalogram.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. age of at least 18 years 2. normal cognitive function at the time of enrollment evidenced by a Mini-Mental State Examination (MMSE) score of more than 24 of 30 3. Chinese Mandarin as the native language 4. providing informed consent Exclusion Criteria: 1. pre-existing delirium assessed according to the Confusion Assessment Method (CAM) 2. history of neurological or psychiatric disease 3. impaired vision or auditory function which may effect the assessments 4. unwillingness to participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei Recruiting

More Huazhong University of Science and Technology trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04832568 on ClinicalTrials.gov ↗ ← All trials in China